Press Release

(September 10, 2020) - Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego. TriLink will consolidate its San Diego facilities into a new 95,000-square-foot space with an option to expand for fut...

(April 1, 2020) - SAN DIEGO  TriLink BioTechnologies®, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, and Imperial College London, a public research university located in the United Kingdom, announced today that they have entered into a partnership in which TriLink will manufacture self-amplifying RNA (saRNA) for CO...

(March 31, 2020) - test

(March 24, 2020) -

(March 24, 2020) - Folio3 Test

In the News

Test Folio3 News

(March 24, 2020) - Folio3 News

Folio3 Test

(Genetic Engineering & Biotechnology News: February 18, 2020) - TriLink BioTechnologies, a leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, announced today that Mike DeMayo has joined the company as vice president of commercial operations. In this role he will be responsible for all TriLink BioTechnologies commercial activities including sales, marketing, technical support and customer service.

Jennifer Dahlgren
Dahlgren Communications
Phone: (530) 263-6817
Email: dahlgrenpr@comcast.net


David Weber, Chief Commercial Officer
Maravai LifeSciences
Phone: (650) 697-3600
Email: david.weber@maravai.com